These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2889257)

  • 1. Clinical benefits of intravenously administered famotidine in the treatment of upper gastrointestinal hemorrhage caused by peptic ulcer and stress ulcer disease.
    Aoki T
    Scand J Gastroenterol Suppl; 1987; 134():41-5. PubMed ID: 2889257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of upper gastro-intestinal bleeding with the H2-receptor antagonist famotidine.
    Aoki T
    J Int Med Res; 1989; 17 Suppl 1():32A-40A. PubMed ID: 2566542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Similar Efficacy of Proton-Pump Inhibitors vs H2-Receptor Antagonists in Reducing Risk of Upper Gastrointestinal Bleeding or Ulcers in High-Risk Users of Low-Dose Aspirin.
    Chan FK; Kyaw M; Tanigawa T; Higuchi K; Fujimoto K; Cheong PK; Lee V; Kinoshita Y; Naito Y; Watanabe T; Ching JY; Lam K; Lo A; Chan H; Lui R; Tang RS; Sakata Y; Tse YK; Takeuchi T; Handa O; Nebiki H; Wu JC; Abe T; Mishiro T; Ng SC; Arakawa T
    Gastroenterology; 2017 Jan; 152(1):105-110.e1. PubMed ID: 27641510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton pump inhibitors versus H2-antagonists: a meta-analysis of their efficacy in treating bleeding peptic ulcer.
    Gisbert JP; González L; Calvet X; Roqué M; Gabriel R; Pajares JM
    Aliment Pharmacol Ther; 2001 Jul; 15(7):917-26. PubMed ID: 11421865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of adjuvant therapies by an H2-receptor antagonist and a proton pump inhibitor after endoscopic treatment in hemostatic management of bleeding gastroduodenal ulcers.
    Sakurada T; Kawashima J; Ariyama S; Kani K; Takabayashi H; Ohno S; Kato S; Yakabi K
    Dig Endosc; 2012 Mar; 24(2):93-9. PubMed ID: 22348833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of recurrent idiopathic gastroduodenal ulcer bleeding: a double-blind, randomised trial.
    Wong GLH; Lau LHS; Ching JYL; Tse YK; Ling RHY; Wong VWS; Chiu PWY; Lau JYW; Chan FKL
    Gut; 2020 Apr; 69(4):652-657. PubMed ID: 31229990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intravenous gastric acid inhibition for stress ulcers and bleeding peptic ulcers].
    Geus WP; Lamers CB
    Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2514-8. PubMed ID: 10627753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endoscopic appearances of hemorrhagic peptic ulcers and efficacy of H2-receptor antagonists.
    Fusamoto H; Kawano S; Tsuji S; Oshita M; Nagano K; Ohmae A; Sawaoka H; Nagai Y; Kasahara A; Sugimoto T; Kamada T
    Hepatogastroenterology; 1996; 43(7):169-73. PubMed ID: 8682457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Continuous intravenous famotidine for haemorrhage from peptic ulcer.
    Walt RP; Cottrell J; Mann SG; Freemantle NP; Langman MJ
    Lancet; 1992 Oct; 340(8827):1058-62. PubMed ID: 1357453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histamine-2 Receptor Antagonist Cannot Prevent Recurrent Peptic Ulcers in Patients With Atherosclerotic Diseases Who Receive Platelet ADP Receptor Antagonist Monotherapy: A Randomized-Controlled, Double-Blind, and Double-Dummy Trial.
    Hsu PI; Wu DC; Tsay FW; Cheng JS; Liu CP; Lai KH; Chen WC; Wang HM; Tsai TJ; Tsai KW; Kao SS
    Am J Gastroenterol; 2017 Feb; 112(2):282-289. PubMed ID: 27922030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Conservative treatment of ulcer hemorrhage with histamine H2 antagonists].
    Grigor'ev PI; Grinberg AA; Toguzova DA; Iakovenko AV; Lopatina IV
    Khirurgiia (Mosk); 1997; (5):63-5. PubMed ID: 9297029
    [No Abstract]   [Full Text] [Related]  

  • 12. Meta-analysis: the efficacy of intravenous H2-receptor antagonists in bleeding peptic ulcer.
    Levine JE; Leontiadis GI; Sharma VK; Howden CW
    Aliment Pharmacol Ther; 2002 Jun; 16(6):1137-42. PubMed ID: 12030956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintenance treatment is not necessary after Helicobacter pylori eradication and healing of bleeding peptic ulcer: a 5-year prospective, randomized, controlled study.
    Liu CC; Lee CL; Chan CC; Tu TC; Liao CC; Wu CH; Chen TK
    Arch Intern Med; 2003 Sep; 163(17):2020-4. PubMed ID: 14504114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are there indications for intravenous acid-inhibition in the prevention and treatment of upper GI bleeding?
    Geus WP
    Scand J Gastroenterol Suppl; 2000; (232):10-20. PubMed ID: 11232484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Famotidine is inferior to pantoprazole in preventing recurrence of aspirin-related peptic ulcers or erosions.
    Ng FH; Wong SY; Lam KF; Chu WM; Chan P; Ling YH; Kng C; Yuen WC; Lau YK; Kwan A; Wong BC
    Gastroenterology; 2010 Jan; 138(1):82-8. PubMed ID: 19837071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Famotidine versus pantoprazole for preventing bleeding in the upper gastrointestinal tract of critically ill patients receiving mechanical ventilation.
    Ojiako K; Shingala H; Schorr C; Gerber DR
    Am J Crit Care; 2008 Mar; 17(2):142-7. PubMed ID: 18310651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled study of the effects of intravenous famotidine on intragastric pH in bleeding peptic ulcers.
    Fullarton GM; Macdonald AM; Mann SG; McColl KE
    Aliment Pharmacol Ther; 1991 Feb; 5(1):77-84. PubMed ID: 1932484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [High-dose omeprazole versus famotidine, pirenzepine and antacid in therapy of acute upper gastrointestinal hemorrhage in a retrospective comparison].
    Busam J; Garbe WE
    Z Gastroenterol; 1994 Feb; 32(2):94-9. PubMed ID: 8165833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent bleeding from peptic ulcer associated with adherent clot: a randomized study comparing endoscopic treatment with medical therapy.
    Bleau BL; Gostout CJ; Sherman KE; Shaw MJ; Harford WV; Keate RF; Bracy WP; Fleischer DE
    Gastrointest Endosc; 2002 Jul; 56(1):1-6. PubMed ID: 12085028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Famotidine: postmarketing clinical experience.
    Saigenji K; Fukutomi H; Nakazawa S
    Scand J Gastroenterol Suppl; 1987; 134():34-40. PubMed ID: 2889256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.